A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 57-63

  Wise, R ^a   Honeybourne, D ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADULT; ARTICLE; BRONCHUS MUCOSA; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; MALE; MAXILLA SINUSITIS; ORAL DRUG ADMINISTRATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION;

EID: 0029924958     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_a.57     Document Type: Article

References (18)

1. Anthonisen, N. R., Manfreda, J., Warren, C. P. W., Hershfeld, E. S., Harding, G. K. M. & Nelson, N. A. (1987). Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Annals of Internal Medicine 106, 196-204.
2. Baldwin, D. R., Honeybourne, D. & Wise, R. (1992a). Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy 36, 1171-5.
3. Baldwin, D. R., Wise, R., Andrews, J. M. & Honeybourne, D. (1992b). Quantitative morphology and water distribution of bronchial biopsy samples. Thorax 47, 504-7.
4. Ball, P. (1990). Overview of experience with ofloxacin in respiratory tract infections. Scandinavian Journal of Infectious Diseases, Suppl. 68, 56-63.
5. Carlier, M. B., Faraji, S. & Tulkens, P. M. (1990). Uptake and subcellular localisation of sparfloxacin in phagocytic cells. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA. 1990. Abstract 1243. American Society for Microbiology, Washington, DC.
6. Cooper, M. A., Andrews, J. M., Ashby, J. P., Matthews, R. S. & Wise, R. (1990). In vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
7. Gehanno, P., Berche, P. and the Sinusitis Study Group. (1996). Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 105-14.
8. Gehanno, P., Farinotti, R., Buffe, P. et al. (1992). Penetration of ciprofloxacin into the middle ear and sinus mucosa after repeated oral administration. In Proceedings of the Fifth Congress for Infectious Diseases, Nairobi, 1992. Abstract 803.
9. Honeybourne, D., Greaves, I., Baldwin, D. R., Andrews, J. M., Harris M. & Wise, R. (1994). The concentration of sparfloxacin in lung tissues after single and multiple oral doses. International Journal of Antimicrobial Agents 4, 151-5.
10. Maesen, F. P. V., Beeukes, H., Davies, B. I., Buytendyk, H. R., Brombacher, P. J. & Wesserman, J. (1976). Bacampicillin in acute exacerbations of chronic bronchitis - a dose range study. Journal of Antimicrobial Chemotherapy 2, 279-85.
11. Massias, L., Cohen, E., Cudennec, Y., Farrinoti, R., Buffe, P. & Gehanno, P. (1993). Distribution of sparfloxacin into the tissue structures of the ENT sphere. In Proceedings of the Eighteenth International Congress of Chemotherapv, Stockholm. Abstract 533.
12. Nix, D. E., Sands, M. F., Peloquin, C. A., Vari, A. J. & Cumbo, T. J. (1987). Dual individualisation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. American Journal of Medicine 82, Suppl. 4A, 352-56.
13. Noone, P., Parson, T. M. C., Pattison, J. R., Slack, R. C. B., Garfield-Davies, D., Hughes, K. (1974). Experience in monitoring gentamicin therapy during treatment of serious Gram-negative sepsis. British Medical Journal i, 477-81.
14. Orr, P. H., Scherer, K., MacDonald, A. & Moffatt, M. E. K. (1993). Randomised placebo-controlled trials of antibiotics for acute bronchitis. Journal of Family Practitioners 36, 507-12.
15. Tulkens, P. M. (1991). Intracellular distribution and activity of antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 10, 100-6.
16. Veyssier, P., Levy, C. & Touron, D. (1994). Diffusion in pleural effusion and tolerance of sparfloxacin administered in a single 400 mg oral dose to 24 subjects. In Proceedings of the Sixth International Congress for Infectious Diseases, Prague, 1994. Abstract 1297, p. 400.
17. Wiebel, E. R. (1969). The ultrastructure of the alveolar-capillary barrier. In The Pulmonary Circulation and Interstitial Space (Fishman, A. O. & Hecht, H. H., Eds), pp. 9-27. University of Chicago Press, Chicago.
18. Wise, R. & Honeybourne, D. (1995). Antibiotic penetration into the respiratory tract - a basis for rational therapy. Chemotherapy 4, 28-32.